Durham Lands $1.4B AbbVie Campus, 734 Jobs Coming

Durham just landed the biggest deal in its history, and it's about to transform thousands of lives.

AbbVie, one of the world's largest pharmaceutical companies, announced plans to build a $1.4 billion manufacturing campus on 185 acres in Durham. The facility will produce immunology, neuroscience, and oncology medicines that help patients worldwide.

The project brings 734 permanent jobs to the Bull City, including positions for engineers, scientists, manufacturing operators, and laboratory technicians. Another 2,000 construction jobs will open up during the building phase, which starts this year and wraps up by late 2028.

Mayor Leo Williams couldn't contain his excitement at Wednesday's announcement. "Durham punched well above its weight, once again outbidding, beating everyone across the entire country to land this employer," he said.

Durham beat major competitors including Illinois and Texas thanks to the region's strong network of universities and training programs. North Carolina Secretary of Commerce Lee Lilley pointed to partnerships with Durham Tech, North Carolina Central University, and Duke as key factors in sealing the deal.

Here's what makes this especially meaningful: these aren't jobs that require fancy degrees to start. City officials say the barrier to entry is low, with many positions perfect for local residents looking to break into the life sciences field.

The average salary will hit six figures. For a city focused on affordability and economic opportunity, that's a game changer.

The Ripple Effect

This investment does more than add jobs. It signals that Durham can compete on a global stage for major employers.

Joshua Gunn, Durham's director of Economic and Workforce Development, sees enormous potential for training partnerships. Local colleges and universities are already preparing programs to help Durham residents land these positions and build careers.

Dr. Mike Lee, Chair of the Durham Board of County Commissioners, highlighted what matters most: "The quality of entry-level jobs included with this announcement provide genuine opportunities for economic mobility." These aren't just jobs; they're pathways to better lives.

The campus will serve as AbbVie's U.S. Center of Excellence for small volume parenteral drug manufacturing. Phase one includes next-generation laboratories, a warehouse, administrative offices, and employee wellness facilities.

For AbbVie, this represents their largest-ever capital investment in a single campus. For Durham, it's proof that investing in education and workforce development pays off in ways that lift entire communities.